Sotac Pharmaceuticals Limited
Incorporated in 2015, Co. is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis
What Sotac files
- Others34
- Board Meeting7
- New Orders5
- Important3
- Dividend/Bonus3
- Updates2
Sotac Pharmaceuticals Limited has provided clarification regarding recent price movements of its shares. The company stated it has disclosed all pertinent information affecting its operations and performance, adhering to regulations governing timely communication with exchanges and stakeholders. There are no pending announcements or material information withheld that could influence the...
Sotac Pharmaceuticals Limited has communicated its compliance with specific exemption criteria under SEBI regulations, indicating that its shares are listed on the SME Emerge Platform. As a result, the company is not obligated to file the quarterly, half-yearly, or yearly Corporate Governance Report. This clarification may suggest a streamlined reporting...
Sotac Pharmaceuticals Limited's board approved the unaudited standalone and consolidated financial results for the half-year ending September 30, 2024. Standalone revenue reached ₹3,061.42 lakhs, with a profit of ₹211.64 lakhs. Consolidated revenue stood at ₹5,259.47 lakhs, yielding a profit of ₹191.25 lakhs. The board reviewed and endorsed additional financial statements,...